Medicare Enrolled

Dr. Vinaitheertha Jeyabarath, M.D.

Cardiovascular Disease · Fort Myers, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
9800 S HEALTHPARK DR STE 320, Fort Myers, FL 33908
2393436350
In practice since 2006 (19 years)
NPI: 1407885692 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jeyabarath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jeyabarath? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jeyabarath

Dr. Vinaitheertha Jeyabarath is a cardiovascular disease in Fort Myers, FL, with 19 years in practice. Based on federal Medicare data, Dr. Jeyabarath performed 1,896 Medicare services across 1,524 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jeyabarath received a total of $2,267 from 26 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jeyabarath is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 1,896 Medicare services$ $2,267 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,896
Medicare services
Bottom 44% in FL for cardiovascular disease
1,524
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~100 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)342$61$139
Office visit, established patient (30-39 min)256$87$200
Initial hospital admission, high complexity240$135$309
Electrocardiogram (EKG), 12-lead184$11$74
Hospital follow-up visit, moderate complexity132$62$121
Hospital follow-up visit, low complexity108$39$56
Echocardiogram, transthoracic71$126$370
Remote pacemaker/defibrillator monitoring, 90 days64$16$55
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec63$28$90
New patient office visit (45-59 min)56$121$348
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days46$20$40
Technetium tc-99m tetrofosmin, diagnostic, per study dose46$351$900
New patient office visit (30-44 min)34$75$226
Remote pacemaker monitoring, 90 days33$23$55
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days31$27$99
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician24$44$150
Nuclear medicine studies of heart muscle at rest and with stress and spect23$330$600
Infusion, normal saline solution, 250 cc23$1$5
Programming of dual lead pacemaker system22$58$98
Injection, aminophyllin, up to 250 mg22$6$20
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician21$16$54
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician21$11$36
Evaluation of implantable heart and blood vessel monitoring system21$28$55
Cardiac catheterization13$236$804
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.6% high complexity
5.9% medium
80.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,267
Total received (2018-2024)
Avg $324/year across 7 years
Bottom 42% in FL for cardiovascular disease
26
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,207 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$111
2023
$305
2022
$448
2021
$529
2020
$309
2019
$271
2018
$294

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$367
Novartis Pharmaceuticals Corporation
$335
Kowa Pharmaceuticals America, Inc.
$253
AstraZeneca Pharmaceuticals LP
$118
Amarin Pharma Inc.
$102
PFIZER INC.
$102
Boston Scientific Corporation
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Abbott Laboratories
$90
Merck Sharp & Dohme LLC
$86
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$85
Novo Nordisk Inc
$81
Astellas Pharma US Inc
$78
Esperion Therapeutics, Inc.
$74
Amgen Inc.
$48
SANOFI-AVENTIS U.S. LLC
$44
iRhythm Technologies, Inc.
$40
Kestra Medical Technology Services, Inc.
$28
Medtronic, Inc.
$27
Medtronic Vascular, Inc.
$24
Merck Sharp & Dohme Corporation
$21
Impulse Dynamics (USA) Inc.
$19
E.R. Squibb & Sons, L.L.C.
$18
Nuwellis, Inc.
$16
MEDICOMP INC
$13
Lundbeck LLC
$12
Top 3 companies account for 42.1% of total payments
Associated products mentioned in payments ›
AQUADEX SMARTFLOW CONSOLE · ASSURITY · Assure WCD · Azure · BRILINTA · CHANTIX · Cardiac Monitor · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Ellipse ICD · FARXIGA · Fortify Assura · GALLANT · GENERAL TACHY · General - Therapies · JARDIANCE · LATITUDE · LEXISCAN · LINQ II · LifeVest · Livalo · MULTAQ · NEXLETOL · NORTHERA · OPTIMIZER · Ozempic · PRADAXA · RESONATE · Repatha · Rybelsus · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN Access System · XARELTO · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $120 per 100 Medicare services performed
Looking for a cardiovascular disease in Fort Myers?
Compare cardiovascular diseases in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
82
Per 100K population
10.3
County median income
$73,099
Nearest hospital
PARK ROYAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jeyabarath is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jeyabarath experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Jeyabarath performed 342 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jeyabarath receive payments from pharmaceutical companies?
Yes. Dr. Jeyabarath received a total of $2,267 from 26 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jeyabarath's costs compare to other cardiovascular diseases in Fort Myers?
Dr. Jeyabarath's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jeyabarath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →